We documented and submitted 17 parts to the iGEM registry
Line 22: | Line 22: | ||
We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP<br><br> | We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP<br><br> | ||
- | These parts were also submitted to the registry | + | These parts were also submitted to the registry<br><br> |
+ | We've condsidered safety by having a safety lecture during our project and by working with several encapsulation methods<br><br> | ||
+ | Together with Synenergene several safety-concerning topics about synthetic biology were discussed and a scenario based on our project was created (see Policy & practices) | ||
+ | |||
}}<html> | }}<html> | ||
Line 28: | Line 31: | ||
<!-- TEST IMAGE MODULE TEMPLATE -> | <!-- TEST IMAGE MODULE TEMPLATE -> | ||
- | </html>{{:Team:Groningen/Template/MODULE/tmpl_imagemodule| | + | </html>{{:Team:Groningen/Template/MODULE/tmpl_imagemodule|Gold badges|b/b7/Gold3.png| |
We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP<br><br> | We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP<br><br> |
We documented and submitted 17 parts to the iGEM registry
We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP
These parts were also submitted to the registry
We've condsidered safety by having a safety lecture during our project and by working with several encapsulation methods
Together with Synenergene several safety-concerning topics about synthetic biology were discussed and a scenario based on our project was created (see Policy & practices)
We validated and characterized the following Biobrick parts from our own project: NisA, and sfGFP
These parts were also submitted to the registry